Roche partnered with Chinese startup Defand Therapeutics to discover new medicines in a deal valued at just under $1 billion if all milestones are achieved.
Agree
Disagree
Overview
Debates
Related claims
Topics
Sources
From the article
Roche does fourth China deal since August, teaming with Defand on degraders
Also in
Roche goes beyond licensing in deal with Chinese biotech
5
52c7ae14
Article
Roche does fourth China deal since August, teaming with Defand on degraders
0
5
52c7ae14
Article
Roche goes beyond licensing in deal with Chinese biotech
0